Myocardial Infarction

In ST-elevation myocardial infarction, selective C-reactive protein apheresis aims to blunt ischemia-reperfusion injury by rapidly lowering circulating CRP early after reperfusion. The CRP-STEMI randomized trial evaluates feasibility, safety, and effects on...

In myocardial infarction , pentameric C-reactive protein may amplify ischemia-reperfusion injury via complement activation and opsonization of damaged myocardium. The CRP-STEMI randomized trial tests selective apheresis to lower circulating CRP as an adjunc...

In ST-elevation myocardial infarction, selective removal of circulating C-reactive protein targets a downstream inflammatory effector implicated in complement activation and opsonization of injured myocardium. A randomized trial will test whether lowering C...

The PROFID EHRA randomized clinical trial launches to evaluate implantable cardioverter-defibrillator use after myocardial infarction through individualized risk stratification. The protocol outlines randomization, endpoints centered on sudden cardiac death...

In acute STEMI, distal radial access may reduce bleeding and radial occlusion while preserving procedural efficiency compared with conventional transradial access. The DR-STEMI randomized protocol compares access strategies during coronary catheterization, ...

After myocardial infarction , prevention of sudden cardiac death with implantable cardioverter defibrillators is being re-evaluated in the PROFID EHRA randomized clinical trial. The protocol tests risk-guided ICD implantation rather than left ventricular ej...

The PROFID EHRA randomized clinical trial targets sudden cardiac death after myocardial infarction by testing risk-guided use of implantable defibrillators. It operationalizes individualized risk stratification beyond left ventricular ejection fraction thre...

In acute myocardial infarction care, distal transradial artery access is being tested against conventional radial cannulation in an international randomized trial. The protocol evaluates feasibility and safety in STEMI, including access success, crossover, ...

In acute myocardial infarction care, distal versus conventional transradial access for emergent coronary catheterization is being tested in a randomized, multicenter protocol. The design specifies access-site and radial artery patency endpoints, procedural ...

In myocardial infarction care, DR-STEMI launches an international, multicenter randomized trial comparing distal versus conventional transradial access for urgent coronary catheterization. The protocol assesses feasibility, procedural efficiency, and access...